Table 3

AORs and 95% CIs logistic regression on polypharmacy adults with diabetes, Electronic Health Records Database, 2016

AOR95% CISignificance
Age group
 30–39 vs 18–291.48(1.00 to 2.18)**
 40–49 vs 18–292.13(1.47 to 3.08)***
 50–59 vs 18–293.54(2.46 to 5.11)***
 60–69 vs 18–295.11(3.51 to 7.44)***
 70–79 vs 18–297.59(5.07 to 11.35)***
> 80 vs 18–299.65(5.69 to 16.38)***
Marital status
 Single versus married1.16(0.96 to 1.40)
Gender
 Female versus male1.60(1.43 to 1.79)***
Nationality
 Non-Saudi versus Saudi1.81(1.50 to 2.19)***
Cardiovascular conditions
 Yes versus no2.89(2.54 to 3.29)***
Musculoskeletal conditions
 Yes versus no3.16(2.31 to 4.30)***
Respiratory conditions
 Yes versus no2.42(1.92 to 3.03)***
Mental health conditions
 Yes versus no2.19(1.74 to 2.76)***
  • Based on 8932 adults with diabetes, who visited outpatient’s clinics from a tertiary hospital in 2016. Polypharmacy was defined as the cumulative use of five or more medications during the 1-year period.

  • Asterisks (*) represent significant differences on polypharmacy compared with the reference group based on logistic regression.

  • *P<0.001, **0.001<P<0.01.

  • AOR, adjusted OR.